Jane Street Group, LLC Incannex Healthcare LTD Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.78 - $2.44 $10,035 - $13,756	-5,638 Reduced 32.58%	11,667 $21,000
Q1 2023 May 15, 2023	SELL	$0.0 - $3.61 $0 - $29,981	-8,305 Reduced 32.43%	17,305 $38,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $4.76 $19,477 - $34,086	7,161 Added 38.82%	25,610 $71,000
Q3 2022 Nov 14, 2022	BUY	$3.44 - $5.57 $63,464 - $102,760	18,449 New	18,449 $81,000
Q2 2022 Aug 16, 2022	SELL	$3.86 - $9.14 $145,965 - $345,629	-37,815 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$9.16 - $35.5 $346,385 - $1.34 Million	37,815 New	37,815 $378,000

Ticker IXHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 51,693,400
Market Cap $94.1M
Description
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.